Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Early data from the TRIUMPH trials is undeniably compelling, showing unprecedented weight loss of up to 28.7% at 68 weeks significantly outpacing tirzepatide in early comparisons (see our Retatrutide vs Tirzepatide comparison guide)
*Average weight-loss figures reflect randomized trials of the FDA-approved branded molecules (SURMOUNT for tirzepatide, STEP for semaglutide), not compounded products, and individual results vary
Sinniger V, Pellissier S, Fauvelle F, Trocme C, Hoffmann D, Vercueil L, Cracowski JL, David O, Bonaz B
In very rare cases, some individuals may not be able to tolerate niacinamide at all or experience an allergic reaction to it
The team at JosephCareRX works with patients to clarify their goals and select the therapy that offers the best balance of efficacy, safety, and convenience
